Immunoglobulin News and Research

RSS
Prevalence of breastmilk feeding among people with SARS-CoV-2 infection during pregnancy

Prevalence of breastmilk feeding among people with SARS-CoV-2 infection during pregnancy

31 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
The potential efficacy of nasal nanoparticle COVID-19 vaccines

The potential efficacy of nasal nanoparticle COVID-19 vaccines

30 Mar 2022
Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

29 Mar 2022
Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

29 Mar 2022
Natural SARS-CoV-2 antibodies persist for six months in children

Natural SARS-CoV-2 antibodies persist for six months in children

28 Mar 2022
Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

28 Mar 2022
Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

28 Mar 2022
Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

27 Mar 2022
SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

27 Mar 2022
How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

25 Mar 2022
Evusheld™ found to poorly neutralize Omicron in kidney transplant patients

Evusheld™ found to poorly neutralize Omicron in kidney transplant patients

25 Mar 2022
Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

25 Mar 2022
IgG Fc glycosylation: A marker for severe COVID-19

IgG Fc glycosylation: A marker for severe COVID-19

24 Mar 2022
Breast milk components show potent in vitro SARS-CoV-2 inhibition

Breast milk components show potent in vitro SARS-CoV-2 inhibition

24 Mar 2022
UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

24 Mar 2022
Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

24 Mar 2022
Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

24 Mar 2022
Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

23 Mar 2022
Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

23 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback